Datexim

Caen, France Founded: 2011 • Age: 15 yrs
AI-driven digital pathology solutions for cervical cancer screening are offered.

About Datexim

Datexim is a company based in Caen (France) founded in 2011 by Arnaud Renouf.. Datexim has raised $2.86 million across 3 funding rounds from investors including European Union, Odyssée Venture and Normandie Participations. Datexim offers products and services including CytoProcessor. Datexim operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Pictor Labs, among others.

  • Headquarter Caen, France
  • Founders Arnaud Renouf
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Datexim
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.86 M (USD)

    in 3 rounds

  • Latest Funding Round
    $1.18 M (USD), Series A

    Oct 12, 2020

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Datexim

Datexim offers a comprehensive portfolio of products and services, including CytoProcessor. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Software for automated screening of cervical cancer cells.

Funding Insights of Datexim

Datexim has successfully raised a total of $2.86M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $1.18 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series A — $1.2M
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2020 Amount Series A - Datexim Valuation

investors

May, 2019 Amount Series A - Datexim Valuation

investors

Mar, 2018 Amount Grant - Datexim Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Datexim

Datexim has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Odyssée Venture and Normandie Participations. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment funds are managed to support growth of French SMEs.
Founded Year Domain Location
Normandie Participations is engaged in regional investment funding.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Datexim

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Datexim

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Datexim Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Datexim

Datexim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Pictor Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
domain founded_year HQ Location
AI and cloud-powered software for stroke care coordination is developed.
domain founded_year HQ Location
AI-powered single cell classification and isolation technology for clinical research
domain founded_year HQ Location
Digital pathology software is developed for clinical and veterinary productivity.
domain founded_year HQ Location
AI-based tools for pathological image analysis are provided to labs.
domain founded_year HQ Location
AI-enabled tools for computational pathology and cancer diagnostics are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Datexim

Frequently Asked Questions about Datexim

When was Datexim founded?

Datexim was founded in 2011 and raised its 1st funding round 7 years after it was founded.

Where is Datexim located?

Datexim is headquartered in Caen, France.

Who is the current CEO of Datexim?

Arnaud Renouf is the current CEO of Datexim. They have also founded this company.

Is Datexim a funded company?

Datexim is a funded company, having raised a total of $2.86M across 3 funding rounds to date.

What does Datexim do?

Datexim was founded in 2011 in Caen, France, and operates within the healthcare sector. Focus is placed on artificial intelligence and digital pathology technologies. Cervical cancer screening processes are enhanced through the CytoProcessor platform, which integrates advances in image analysis and automation. Services are provided to medical laboratories and institutions seeking improved diagnostic efficiency in pathology workflows.

Who are the top competitors of Datexim?

Datexim's top competitors include Deciphex, Pictor Labs and PathAI.

What products or services does Datexim offer?

Datexim offers CytoProcessor.

Who are Datexim's investors?

Datexim has 3 investors. Key investors include European Union, Odyssée Venture, and Normandie Participations.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available